Dengue Virus-Like Particle Vaccine
Abstract
The aim of the project was to develop and validate Dengue virus (DENV) VLP based vaccines for the elicitation of broadly reactive immune responses. This approach built on expertise and tools already developed by the members of the University of Pittsburgh's Center for Vaccine Research for Emerging Diseases and Biodefense.
Document Details
- Document Type
- Technical Report
- Publication Date
- Jul 01, 2011
- Accession Number
- AD1064671
Entities
People
- Charles Rinaldo
Organizations
- University of Pittsburgh Medical Center